EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudie

Long‐term cognitive function changes with non‐vitamin K oral anticoagulants in older patients with atrial fibrillation. A multicenter cohort study

Giuseppe Armentaro iD, Graziella D'Arrigo, Daniele Pastori iD, Giulia Crudo, Mario Daidone, Luca Soraci iD, Carlo Alberto Pastura, Marcello Divino, Annalisa Pitino, Mercedes Gori, Giovanni Tripepi, Egidio Imbalzano und 5 weitere

European Journal of Clinical Investigation · 2025

DOI: 10.1111/eci.14321 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Clinical Investigation, 2025. Verfasst von Giuseppe Armentaro und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Cognitive Dysfunction, Vitamin K. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation is associated with several comorbidities, particularly cognitive impairment and dementia, especially in older patients. Non‐vitamin K oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) were used to prevent thromboembolic events. However, data on the real benefit of these drugs on cognitive function decline remains controversial. In this study we evaluated the effect of NOACs compared to VKAs on the absolute and relative decline in cognitive function over time.

Methods

Nine hundred and eighty‐three older patients with nonvalvular AF were enrolled (76 ± 6 years; 291 on VKAs and 692 on NOACs). The cognitive function was assessed with Mini Mental State examination (MMSE) score. The between‐arms difference of cognitive evolution over time was investigated by Linear Mixed Models and group‐based trajectory model analyses.

Results

In the whole multicenter observational study, after a long follow‐up of 7.2 ± 3.4 years, the patients of the NOACs versus VKAs group had lowest absolute reduction of the MMSE score between baseline and follow‐up (−0.3 ± 0.03 vs.−1.7 ± 0.1, p < 0.001). After stratification into five subgroups according to trajectories of MMSE score over time, the probability to belong to trajectories with lower decline in cognitive functions was higher in patients on NOACs than in those on VKAs (3.93–13.88 times).

Conclusion

In older patients with atrial fibrillation, the use of NOACs was associated with a smaller decline of cognitive function over time compared to the VKAs, regardless that patients in the NOACs group were older and with a higher burden of comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsCognitive DysfunctionVitamin KHumansAgedFemaleMaleAged, 80 and overCohort StudiesAdministration, OralCognitionMental Status and Dementia TestsFactor Xa InhibitorsRivaroxabanPyridonesDabigatranPyrazoles

Stichwörter der Autor:innen

NOACsVKAsatrial fibrillationcognitive impairmentolder

Substanzen

AnticoagulantsVitamin KFactor Xa InhibitorsRivaroxabanPyridonesapixabanDabigatranPyrazoles

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy.
  • Institute of Clinical Physiology (IFC-CNR), Section of Reggio Calabria, Reggio Calabria, Italy.
  • Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
  • Internal Medicine and Stroke Care Ward, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Unit of Geriatric Medicine, IRCCS INRCA, Cosenza, Italy.
  • Institute of Clinical Physiology (IFC-CNR), Section of Rome, Rome, Italy.

ORCID-Profile: Giuseppe Armentaro, Daniele Pastori, Luca Soraci

Zitieren

APA

Armentaro, G., D'Arrigo, G., Pastori, D., Crudo, G., Daidone, M., Soraci, L., Pastura, C. A., Divino, M., Pitino, A., Gori, M., Tripepi, G., Imbalzano, E., Corsonello, A., Pignatelli, P., Andreozzi, F., Tuttolomondo, A., & Sciacqua, A. (2025). Long‐term cognitive function changes with non‐vitamin K oral anticoagulants in older patients with atrial fibrillation. A multicenter cohort study. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14321

Vancouver

Armentaro G, D'Arrigo G, Pastori D, Crudo G, Daidone M, Soraci L, et al. Long‐term cognitive function changes with non‐vitamin K oral anticoagulants in older patients with atrial fibrillation. A multicenter cohort study. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.14321

BibTeX
@article{Armentaro2025,
  author = {Armentaro, Giuseppe and D'Arrigo, Graziella and Pastori, Daniele and Crudo, Giulia and Daidone, Mario and Soraci, Luca and Pastura, Carlo Alberto and Divino, Marcello and Pitino, Annalisa and Gori, Mercedes and Tripepi, Giovanni and Imbalzano, Egidio and Corsonello, Andrea and Pignatelli, Pasquale and Andreozzi, Francesco and Tuttolomondo, Antonino and Sciacqua, Angela},
  title = {Long‐term cognitive function changes with non‐vitamin K oral anticoagulants in older patients with atrial fibrillation. A multicenter cohort study},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1111/eci.14321}
}
Kostenlos starten →